Effect of postmenopausal hormone therapy on body weight and waist and hip girths

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 5, 1997, Pages 1549-1556

  Espeland, Mark A ^a   Stefanick, Marcia L ^b   Kritz Silverstein, Donna ^c   Fineberg, S Edwin ^d   Waclawiw, Myron A ^e   James, Margaret K ^a   Greendale, Gail A ^f  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d INDIANA UNIVERSITY   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; MEDROXYPROGESTERONE ACETATE; PROGESTERONE;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY FAT; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTROGEN THERAPY; ETHNOLOGY; FEMALE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OBESITY; ORAL DRUG ADMINISTRATION; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; WEIGHT GAIN;

EID: 0030918240     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.5.1549     Document Type: Article

References (50)

1. Hjorkland MC, McNamara PM, Kannel WB. 1976 Some atherogenic concomitants of menopause: The Framingham Study. Am J Epidemiol. 103:304-311.
2. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR. 1989 Menopause and risk factors for coronary heart disease. N Engl J Med. 321:641-646.
3. Kuller LH, Meilahn EN, Gutai J, et al. 1990 Lipoproteins, estrogens, and the menopause. In: Korenman SG, ed. The menopause: biological and clinical consequences of ovarian failure: evolution and management. Norwell: Serono Symposia; 000-000.
4. Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantinga PL. 1991 Weight gain at the time of menopause. Arch Intern Med. 151:97-102.
5. Manson JE, Colditz GA, Stampfer MJ, et al. 1990 A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med. 322:882-889.
6. Nachtigall LE. 1990 Enhancing patient compliance with hormone replacement therapy at menopause. Obstet Gynecol. 75(Suppl):77-80.
7. Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH. 1985 A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med. 212:1044-1049.
8. Aloia JF, Vaswani A, Russo L, Sheehan M, Flaster E. 1995 The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass. Am J Obstet Gynecol. 172:896-900.
9. Kritz-Silverstein D, Barrett-Connor E. 1996 Long-term postmenopausal hormone use, obesity, and fat distribution in older women. JAMA. 275:46-49.
10. The Writing Group for the PEPI Trial. 1995 Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. JAMA. 273:199-208.
11. Reubinoff BE, Wurtman J, Rojansky N, et al. 1995 Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women: a prospective study. Fertil Steril. 64:963-968.
12. Manolio TA, Furberg CD, Shemanski L, et al. 1993 Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. Circulation. 88:2163-2171.
13. Utian WH. 1978 Effect of postmenopausal estrogen therapy on diastolic blood pressure and body weight. Maturitas. 1:3-8.
14. Haarbo J, Marslew U, Gotfredsen A, Christiansen C. 1991 Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism. 40:1323-1326.
15. Notelovitz M. 1975 The effect of oral oestrogens on blood pressure and weight in postmenopausal women. S Afr Med J. 49:2251-2254.
16. Wing RR, Matthews KA, Kuller LH, et al. 1992 Environmental and familial contributions to insulin levels and change in insulin levels in middle-age women. JAMA. 268:1890-1895.
17. Pasquali R, Casimirri F, Labate AMM, et al. 1994 Body weight, fat distribution and the menopausal status in women. Int J Obesity. 18:614-621.
18. Espeland MA, Bush TL, Mebane-Sims I, et al. 1995 Rationale, design and conduct of the PEPI Trial. Controlled Clin Trials. 16:3S-19S.
19. Wood PD, Kessler G, Lippel K, Stefanick ML, Wasilauskas CH, Wells HB. 1995 Physical and laboratory measurements in the PEPI Trial. Controlled Clin Trials. 16:36S-53S.
20. Miller VT, Byington RL, Espeland MA, et al. 1995 Baseline characteristics of the PEPI participants. Controlled Clin Trials. 16:54S-65S.
21. Greendale GA, Bodin-Dunn L, Ingles S, Haile R, Barrett-Connor E. 1996 Leisure, home, and occupational physical activity and cardiovascular risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) study. Arch Intern Med. 156:418-424.
22. Laird NM, Ware JH. 1982 Random-effects models for longitudinal data. Biometrics. 38:963-74.
23. Jennrich RI, Schluchter MD. 1986 Unbalanced repeated measures models with structured covariance matrices. Biometrics. 42:805-20.
24. SAS Institute. 1992 SAS Technical Report P-229, SAS/STAT Software: Changes and Enhancements, release 6.06. Cary: SAS Institute.
25. Stefanick ML. 1993 The roles of obesity, regional adiposity, and physical activity in coronary heart disease in women. In: Wenger NK, Speroff L, Packart B, eds. Cardiovascular health and disease in women. Greenwich: Le Jacq Communications; 149-156.
26. Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckman EM. 1979 Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. Obstet Gynecol. 54:74-79.
27. Kaye SA, Folsom AR, Prineas RJ, Potter JD, Gapstur SM. 1990 The associations of body fat distribution with lifestyle and reproductive factors in a population study of postmenopausal women. Int J Obesity. 14:583-591.
28. Tonkellar ID, Seidell JC, Van Noord PAH, Baanders-van Halewijn EA, Jabobus JH, Bruning PF. 1989 Factors influencing waist/hip ratio in randomly selected pre- and post-menopausal women in the DOM-project (preliminary results). Int J Obesity. 13:817-824.
29. Wing RR, Mathews KA, Kuller LH, Meilahn EN, Plantiga P. 1991 Waist to hip ratio in middle aged women. Associations with behavioral and psychosocial factors and with changes in cardiovascular risk factors. Arterioscler Thromb. 11:1250-1257.
30. Tavani A, Negri E, La Vecchia C. 1994 Determinants of body mass index: a study from northern Italy. Int J Obesity Relat Metab Disord. 18:497-502.
31. Baumgartner RN, Heymsfield SB, Roche AF. 1995 Human body composition and the epidemiology of chronic disease. Obesity Res. 3:73-95.
32. Zamboni M, Armellini F, Milani MP, et al. 1992 Body fat distribution in pre-ancl post-menopausal women: metabolic and anthropometric variables and their inter-relationships. Int J Obesity Relat Metab Disord. 16:495-504.
33. Haarbo J, Marslew U, Gotfredsen A, Christiansen C. 199 Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism. 12:1323-1326.
34. Stefanick ML. 1993 Exercise and weight control. In: Holloszy JO, ed. Exercise and sport sciences reviews. American College of Sports Medicine Series. Baltimore: Williams and Wilkins; vol 21:363-396.
35. Bassford TL. 1995 Health status of Hispanic elders. Clin Geriatr Med. 11:25-38.
36. Kumanyika SK. 1993 Special issues regarding obesity in minority populations. Ann Intern Med. 119:650-654.
37. Barrett-Connor E, Khaw K-T. 1981 Cigarette smoking and cerebral adiposity. Ann Intern Med. 11:783-787.
38. Jensen EX, Fusch CH, Jaeger P, Peheim E, Horber FF. 1995 Impact of chronic cigarette smoking on body composition and fuel metabolism. J Clin Endocrinol Metab. 80:2181-2185.
39. Keil DP, Baron JA, Anderson JJ, Hannan MT, Felson DT. 1992 Smoking eliminates the protective effect of oral estrogens on the risk of hip fracture among women. Ann Intern Med. 116:716-721.
40. Baron J. 1984 Smoking and estrogen-related disease. Am J Epidemiol. 119:9-22.
41. Michnovicz JJ, Hershcopf RJ, Naganuma H, Bradlow HL, Fishman J. 1986 Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogen effect of cigarette smoking. N Engl J Med. 315:1305-1309.
42. Jensen J, Christiansen C, Rodbro P. 1985 Cigarette smoking, serum estrogens and bone loss during hormone-replacement early after menopause. N Engl J Med. 313:973-975.
43. Flatt JP. 1987 Dietary fat, carbohydrate balance and weight maintenance: effects of exercise. Am J Clin Nutr. 75:296-306.
44. Schutz Y, Tremblay A, Weisner RL, Nelson KM. 1992 Role of fat oxidation in the long term stabilization of body weight in obese women. Am J Clin Nutr. 55:670-674.
45. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YDI, Reaven GM. 1992 Insulin resistance and cigarette smoking. Lancet. 339:1128-1130.
46. Larue-Achagiotis C, Poussard AM. Loius-Sylvestre J. 1990 Alcohol drinking, food and fluid intakes and body weight gain in rats. Physiol Behav. 47:545-548.
47. Kaye SA, Folsom AR, Prineas RJ, Potter JD, Gapstur SM. 1990 The association of body fat distribution with lifestyle and reproductive factors in a population study of postmenopausal women. Int J Obesity. 14:583-591.
48. Dada OA, Martins OO. 1983 Drug effects on the internal absorption of estrogens. J Steroid Biochem. 19:821-825.
49. Gavaler JS. 1985 Effects of alcohol on endocrine function in postmenopausal women: a review. J Studies Alcohol. 46:495-516.
50. Zeiner AR, Kegg PS. 1981 Effects of sex steroids on ethanol pharmacokinetics and autonomic reactivity. Prog Biochem Pharmacol. 18:130-142.